Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,544 | 1,422 | 99.4% |
| Education | $72.28 | 7 | 0.3% |
| Gift | $59.40 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,626 | 164 | $0 (2024) |
| Novo Nordisk Inc | $3,343 | 230 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,109 | 190 | $0 (2024) |
| PFIZER INC. | $2,635 | 190 | $0 (2024) |
| Lilly USA, LLC | $1,485 | 92 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,452 | 87 | $0 (2024) |
| ABBVIE INC. | $1,037 | 64 | $0 (2024) |
| Amgen Inc. | $726.86 | 38 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $650.35 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $648.38 | 42 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,587 | 130 | AstraZeneca Pharmaceuticals LP ($658.62) |
| 2023 | $3,318 | 164 | AstraZeneca Pharmaceuticals LP ($666.83) |
| 2022 | $2,958 | 173 | AstraZeneca Pharmaceuticals LP ($374.88) |
| 2021 | $2,855 | 167 | Novo Nordisk Inc ($367.99) |
| 2020 | $2,430 | 155 | Novo Nordisk Inc ($475.71) |
| 2019 | $2,987 | 208 | GlaxoSmithKline, LLC. ($582.58) |
| 2018 | $3,284 | 216 | Novo Nordisk Inc ($762.39) |
| 2017 | $3,257 | 217 | Novo Nordisk Inc ($604.13) |
All Payment Transactions
1,430 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.97 | General |
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: PAIN | ||||||
| 12/04/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/26/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Vaccines | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.69 | General |
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: PAIN | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: VACCINES | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Biological | ||||||
| 10/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: VACCINES | ||||||
| 10/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.19 | General |
| 10/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: UROLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 376 | 629 | $40,202 | $24,959 |
| 2022 | 7 | 341 | 398 | $35,547 | $22,929 |
| 2021 | 8 | 352 | 400 | $33,234 | $22,129 |
| 2020 | 8 | 267 | 312 | $28,475 | $16,008 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 136 | $18,360 | $10,362 | 56.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 51 | 51 | $8,211 | $6,363 | 77.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 23 | $4,186 | $2,595 | 62.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 33 | $3,300 | $2,085 | 63.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 55 | 55 | $1,650 | $1,396 | 84.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 55 | 55 | $1,375 | $965.25 | 70.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 54 | 54 | $1,350 | $947.70 | 70.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 22 | $770.00 | $227.01 | 29.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 15 | 200 | $1,000 | $18.67 | 1.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 128 | $17,280 | $9,939 | 57.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 50 | 50 | $8,050 | $6,297 | 78.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 36 | $3,600 | $2,140 | 59.5% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 58 | 58 | $1,740 | $1,528 | 87.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 58 | 58 | $1,450 | $1,049 | 72.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 57 | 57 | $1,425 | $1,013 | 71.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $2,002 | $962.48 | 48.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 111 | $14,985 | $8,807 | 58.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 49 | 49 | $7,889 | $6,221 | 78.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 32 | $3,160 | $1,922 | 60.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2021 | 59 | 59 | $1,770 | $1,560 | 88.1% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 59 | 59 | $1,475 | $1,052 | 71.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 59 | 59 | $1,475 | $1,052 | 71.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 16 | $1,590 | $894.45 | 56.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 12 | 15 | $890.00 | $622.30 | 69.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 65 | 95 | $12,825 | $6,074 | 47.4% |
About Dr. Scott Simeon, M.D
Dr. Scott Simeon, M.D is a Internal Medicine healthcare provider based in Kenner, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093784696.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Simeon, M.D has received a total of $23,675 in payments from pharmaceutical and medical device companies, with $2,587 received in 2024. These payments were reported across 1,430 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($23,544).
As a Medicare-enrolled provider, Simeon has provided services to 1,336 Medicare beneficiaries, totaling 1,739 services with total Medicare billing of $86,025. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics
- Location Kenner, LA
- Active Since 03/16/2006
- Last Updated 02/20/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093784696
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,807
- FARXIGA (Drug) $1,612
- Ozempic (Drug) $1,599
- JARDIANCE (Drug) $1,111
- NURTEC ODT (Drug) $919.48
- TRULICITY (Drug) $774.01
- ELIQUIS (Drug) $730.27
- UBRELVY (Drug) $710.32
- Victoza (Drug) $688.90
- Kerendia (Drug) $650.35
- PREVNAR - 13 (Biological) $553.00
- SYMBICORT (Drug) $496.24
- ANORO (Drug) $477.14
- STIOLTO RESPIMAT (Drug) $428.11
- XARELTO (Drug) $417.29
- Tresiba (Drug) $403.78
- QULIPTA (Drug) $380.54
- BREZTRI (Drug) $363.30
- SHINGRIX (Biological) $347.27
- Prolia (Biological) $331.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kenner
Conar Fitton, M.d, M.D
Internal Medicine — Payments: $777,730
Jose Barrientos Paz
Internal Medicine — Payments: $10,381
Sanjin Tunovic, M.d, M.D
Internal Medicine — Payments: $7,994
Najy Masri, Md, MD
Internal Medicine — Payments: $7,230
Anjuman Ara, Md, MD
Internal Medicine — Payments: $1,503
Betty Lo, Md, MD
Internal Medicine — Payments: $996.86